BTA
Click for more information
0.00% 57.0¢ biota holdings limited

peramivir disappoints in results, page-3

  1. dma
    4,618 Posts.
    clock Created with Sketch.
    20/09/07
    20:19
    Post #: 2823389
    BNRICH..............Pretty poor results for Peramivir....................won,t be long before they will be upgrading Relenza/Zanamivir..............from what I have been reading, looks like the scientific community already knows the answer, that Zanamivir/Relenza is superior. Good article.

    Cheers dma
    BTA Price at posting: 0.0¢ Sentiment: Buy Disclosure: Not Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

MGU Collaboration in a green (steel) future the focus for Magnum and Saudi partners
right-arrow Created with Sketch.
NXG Cost blow-out for Rook I uranium project sees share plummet for NexGen
right-arrow Created with Sketch.
NEWS Week 31 Wrap: JORC rules to get tougher; RBA rate hike chance 50/50; US Fed Sept cut still the quo
right-arrow Created with Sketch.
NEWS A Super PITch is key in the competition for capital
right-arrow Created with Sketch.
NEWS Diggers & Dealers 2024: Kim Beazley ties mining and military together; highlights competition with China in Africa
right-arrow Created with Sketch.
WGX Westgold sets its sights on top five producer status through merger with Karora
right-arrow Created with Sketch.
watchlist Created with Sketch. Add BTA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.